Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
May 1, 2018
Patent Application Number
15820157
Date Filed
November 21, 2017
Patent Primary Examiner
Patent abstract
The present invention relates to the field of cancer therapy. Specifically, provided are methods of treating cancer, for example, peripheral T-cell lymphoma (“PTCL”), with a farnesyltransferase inhibitor (FTI) that include determining whether the subject is likely to be responsive to the FTI treatment based on gene expression characteristics.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
